RBC Capital analyst Ben Hendrix lowered the firm’s price target on CVS Health (CVS) to $58 from $68 and keeps an Outperform rating on the ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...

Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing ...

Threads app was launched in July last year as a challenger to X, formerly Twitter, in a bid to win users from the de facto ...

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

A number of analysts have downgraded estimates for CVS Health CVS following the pharmacy benefit and retail pharmacy stalwart ...

Further, Tata Motors posted a cautious commentary. "We remain cautious on near-term domestic demand," it said in the ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

Originally designated as “Armistice Day” by President Woodrow Wilson in 1919, the day was established to honor veterans of World War I. However, in 1954, Dwight D. Eisenhower proclaimed it a holiday ...

Retailers' investments have ranged from strategic pivots for existing clinics to multibillion-dollar acquisitions of primary ...

In a post earnings chat, Managing Director & CEO, Ashok Leyland said, heatwaves, uneven monsoon and elections impacted CV ...

The stock climbed 2.69% to Rs 827.45. Market cap of the firm rose to Rs 3.30 lakh crore in the current session.